Archer Materials Ltd
ASX:AXE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.215
0.475
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Archer Materials Ltd
Archer Materials Ltd. focuses on developing and commercializing global industries of quantum technology, human health, and reliable energy. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-08-14. The firm is focused on developing and commercializing deep technology, including quantum computing and biotech. The firm is progressing the development of 12CQ quantum computing processor chip and A1 Biochip lab-on-a-chip technology. The 12CQ chip allow for quantum computing onboard mobile devices for speed ups and increased power in artificial intelligence, big data, and fintech applications. The firm is developing biochip using graphene-based materials as integrated circuits, to form the sensing elements in its biochip.
Archer Materials Ltd. focuses on developing and commercializing global industries of quantum technology, human health, and reliable energy. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-08-14. The firm is focused on developing and commercializing deep technology, including quantum computing and biotech. The firm is progressing the development of 12CQ quantum computing processor chip and A1 Biochip lab-on-a-chip technology. The 12CQ chip allow for quantum computing onboard mobile devices for speed ups and increased power in artificial intelligence, big data, and fintech applications. The firm is developing biochip using graphene-based materials as integrated circuits, to form the sensing elements in its biochip.
